Literature DB >> 26123324

MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia.

Veena S Patel1, Sinead Kelly2, Carrie Wright3, Cota Navin Gupta4, Alejandro Arias-Vasquez5, Nora Perrone-Bizzozero6, Stefan Ehrlich7, Lei Wang8, Juan R Bustillo9, Derek Morris10, Aiden Corvin11, Dara M Cannon12, Colm McDonald13, Gary Donohoe14, Vince D Calhoun15, Jessica A Turner16.   

Abstract

Genome-wide association studies implicate the MIR137HG risk variant rs1625579 (MIR137HGrv) within the host gene for microRNA-137 as a potential regulator of schizophrenia susceptibility. We examined the influence of MIR137HGrv genotype on 17 subcortical and callosal volumes in a large sample of individuals with schizophrenia and healthy controls (n=841). Although the volumes were overall reduced relative to healthy controls, for individuals with schizophrenia the homozygous MIR137HGrv risk genotype was associated with attenuated reduction of mid-posterior corpus callosum volume (p=0.001), along with trend-level effects in the adjacent central and posterior corpus callosum. These findings are unique in the literature and remain robust after analysis in ethnically homogenous and single-scanner subsets of the larger sample. Thus, our study suggests that the mechanisms whereby MIR137HGrv works to increase schizophrenia risk are not those that generate the corpus callosum volume reductions commonly found in the disorder.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Corpus callosum; MIR137; Multi-site; Schizophrenia; Subcortical volume; microRNA-137

Mesh:

Substances:

Year:  2015        PMID: 26123324      PMCID: PMC4532634          DOI: 10.1016/j.neulet.2015.06.039

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

1.  MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1.

Authors:  Richard D Smrt; Keith E Szulwach; Rebecca L Pfeiffer; Xuekun Li; Weixiang Guo; Manavendra Pathania; Zhao-Qian Teng; Yuping Luo; Junmin Peng; Angelique Bordey; Peng Jin; Xinyu Zhao
Journal:  Stem Cells       Date:  2010-06       Impact factor: 6.277

2.  Topography of the human corpus callosum revisited--comprehensive fiber tractography using diffusion tensor magnetic resonance imaging.

Authors:  Sabine Hofer; Jens Frahm
Journal:  Neuroimage       Date:  2006-07-18       Impact factor: 6.556

3.  Identification of loci associated with schizophrenia by genome-wide association and follow-up.

Authors:  Michael C O'Donovan; Nicholas Craddock; Nadine Norton; Hywel Williams; Timothy Peirce; Valentina Moskvina; Ivan Nikolov; Marian Hamshere; Liam Carroll; Lyudmila Georgieva; Sarah Dwyer; Peter Holmans; Jonathan L Marchini; Chris C A Spencer; Bryan Howie; Hin-Tak Leung; Annette M Hartmann; Hans-Jürgen Möller; Derek W Morris; Yongyong Shi; GuoYin Feng; Per Hoffmann; Peter Propping; Catalina Vasilescu; Wolfgang Maier; Marcella Rietschel; Stanley Zammit; Johannes Schumacher; Emma M Quinn; Thomas G Schulze; Nigel M Williams; Ina Giegling; Nakao Iwata; Masashi Ikeda; Ariel Darvasi; Sagiv Shifman; Lin He; Jubao Duan; Alan R Sanders; Douglas F Levinson; Pablo V Gejman; Sven Cichon; Markus M Nöthen; Michael Gill; Aiden Corvin; Dan Rujescu; George Kirov; Michael J Owen; Nancy G Buccola; Bryan J Mowry; Robert Freedman; Farooq Amin; Donald W Black; Jeremy M Silverman; William F Byerley; C Robert Cloninger
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

4.  Can FreeSurfer Compete with Manual Volumetric Measurements in Alzheimer's Disease?

Authors:  Lies Clerx; Ed H B M Gronenschild; Carmen Echavarri; Frans Verhey; Pauline Aalten; Heidi I L Jacobs
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

5.  The corpus callosum, the other great forebrain commissures, and the septum pellucidum: anatomy, development, and malformation.

Authors:  Charles Raybaud
Journal:  Neuroradiology       Date:  2010-04-27       Impact factor: 2.804

6.  A longitudinal study of the corpus callosum in chronic schizophrenia.

Authors:  Serge A Mitelman; Yekaterina K Nikiforova; Emily L Canfield; Erin A Hazlett; Adam M Brickman; Lina Shihabuddin; Monte S Buchsbaum
Journal:  Schizophr Res       Date:  2009-08-26       Impact factor: 4.939

7.  Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia.

Authors:  Roberto Gasparotti; Paolo Valsecchi; Francesco Carletti; Alessandro Galluzzo; Roberto Liserre; Bruno Cesana; Emilio Sacchetti
Journal:  Schizophr Res       Date:  2008-12-21       Impact factor: 4.939

Review 8.  Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Authors:  Aristotle N Voineskos
Journal:  Schizophr Res       Date:  2014-06-02       Impact factor: 4.939

9.  Morphology of the corpus callosum at different stages of schizophrenia: cross-sectional study in first-episode and chronic illness.

Authors:  Mark Walterfang; Amanda G Wood; David C Reutens; Stephen J Wood; Jian Chen; Dennis Velakoulis; Patrick D McGorry; Christos Pantelis
Journal:  Br J Psychiatry       Date:  2008-06       Impact factor: 9.319

10.  Distribution of tract deficits in schizophrenia.

Authors:  Ian Ellison-Wright; Pradeep J Nathan; Edward T Bullmore; Rashid Zaman; Robert B Dudas; Mark Agius; Emilio Fernandez-Egea; Ulrich Müller; Chris M Dodds; Natalie J Forde; Cathy Scanlon; Alexander Leemans; Colm McDonald; Dara M Cannon
Journal:  BMC Psychiatry       Date:  2014-04-02       Impact factor: 3.630

View more
  8 in total

Review 1.  A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.

Authors:  Kensuke Sakamoto; James J Crowley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-06-14       Impact factor: 3.568

2.  Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development.

Authors:  Kristy R Howell; Amanda J Law
Journal:  Schizophr Res       Date:  2019-09-12       Impact factor: 4.939

3.  Multimodal Neuroimaging in Schizophrenia: Description and Dissemination.

Authors:  C J Aine; H J Bockholt; J R Bustillo; J M Cañive; A Caprihan; C Gasparovic; F M Hanlon; J M Houck; R E Jung; J Lauriello; J Liu; A R Mayer; N I Perrone-Bizzozero; S Posse; J M Stephen; J A Turner; V P Clark; Vince D Calhoun
Journal:  Neuroinformatics       Date:  2017-10

Review 4.  microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease.

Authors:  Kristen T Thomas; Christina Gross; Gary J Bassell
Journal:  Front Mol Neurosci       Date:  2018-12-12       Impact factor: 5.639

5.  Association of MIR137 With Symptom Severity and Cognitive Functioning in Belarusian Schizophrenia Patients.

Authors:  Hanna Kandratsenka; Anastasiya Nestsiarovich; Inna Goloenko; Nina Danilenko; Anna Makarevich; Victor Obyedkov; Oleg Davydenko; Napoleon Waszkiewicz
Journal:  Front Psychiatry       Date:  2018-07-05       Impact factor: 4.157

Review 6.  Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia.

Authors:  Andrew Gibbons; Madhara Udawela; Brian Dean
Journal:  Noncoding RNA       Date:  2018-04-12

Review 7.  MicroRNAs in the Onset of Schizophrenia.

Authors:  Kristen T Thomas; Stanislav S Zakharenko
Journal:  Cells       Date:  2021-10-06       Impact factor: 6.600

8.  Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia.

Authors:  C Wright; C N Gupta; J Chen; V Patel; V D Calhoun; S Ehrlich; L Wang; J R Bustillo; N I Perrone-Bizzozero; J A Turner
Journal:  Transl Psychiatry       Date:  2016-02-02       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.